FLT4 and diabetic kidney disease: Selective inhibition of VEGFR-3 to suppress lymphoproliferation in DKD mice has been shown to reduce plasma cholesterol levels, free fatty acids, and proteinuria, thereby reducing kidney inflammation and oxidative stress and attenuating kidney fibrosis [32].